Publications by authors named "A I al-Sharif"

Background: This study aimed to evaluate the retention in care among a cohort of Egyptian people living with HIV (PLWHIV).

Method: The study was conducted on PLWHIV attending Kasr Alainy HIV and Viral Hepatitis Centre, Cairo, Egypt, from January 1, 2019, to March 31, 2023. PLWHIV were considered not retained in care if there was no documented clinical visit or HIV viral load (VL) or CD4 count test for more than 6 months from their last recorded visit or test.

View Article and Find Full Text PDF
Article Synopsis
  • Classical hemophilia A is an X-linked recessive disorder that results in a deficiency of factor VIII, leading to severe bleeding disorders, including the rare complication of spontaneous retroperitoneal hematomas.
  • A case study of a 38-year-old man with hemophilia A demonstrated a significant internal bleeding event, requiring urgent medical intervention, blood transfusions, and treatment with factor VIII and recombinant factor VIIa.
  • The case highlights that spontaneous retroperitoneal hematomas are serious emergencies in hemophilia A patients, emphasizing the importance of accurate diagnosis and careful management to prevent severe outcomes.
View Article and Find Full Text PDF

Introduction: Medication use during pregnancy is limited by the scarcity of safety data for many drugs. The use of certain drugs during pregnancy can be teratogenic. Overestimating teratogenic medication risk could have serious consequences from drug non-adherence.

View Article and Find Full Text PDF

Background And Study Aims: Liver dysfunction is a common manifestation of the COVID-19 infection. We aimed to study transaminase abnormalities through different waves of COVID-19 and their relations to disease severity or mortality.

Patients And Methods: A retrospective study included 521 Egyptian patients diagnosed with COVID-19.

View Article and Find Full Text PDF

Cardiovascular disease (CVD) is a critical public health issue in Saudi Arabia, where it is the leading cause of death. The economic burden of CVD in the country is expected to triple by 2035, reaching $9.8 billion.

View Article and Find Full Text PDF